MANAGEMENT OF NON SEPTIC PATIENTS SUFFERING FROM PARTIAL THICKNESS BURNS DURING THE FIRST 48 POSTBURN HOURS BY ADMINISTRATION OF ACTIVATED PROTEIN C
This invention relates to the management of the early stages of burns and burn victim, suffering from partial thickness burns with the administration of activated protein C and a Topical bactericidal agent as Povidone-Iodine, in order to reduce the total burn injury during the first post burn week....
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This invention relates to the management of the early stages of burns and burn victim, suffering from partial thickness burns with the administration of activated protein C and a Topical bactericidal agent as Povidone-Iodine, in order to reduce the total burn injury during the first post burn week. The protein C enzyme system represents a major physiological mechanism of anti-coagulation, anti-inflammation and fibrinolysis, which is beneficial for the rapid healing of the Zone II (Zone of Stasis) in burns.
Cette invention concerne la science médicale, en particulier le traitement des premiers stades de brûlures et d'une victime de brûlure souffrant de brûlures d'épaisseur partielle par administration de protéine C activée et d'un agent bactéricide topique, tel que la povidone iodée afin de réduire la lésion de brûlure totale pendant la première semaine après la brûlure. Le système enzymatique de la protéine C représente un mécanisme physiologique majeur d'anti-coagulation, d'anti-inflammation et de fibrinolyse, qui est utile pour la guérison rapide de la zone II (zone de stase) dans les brûlures. |
---|